| 1. Brett AS, Phillips D, Lynn AW. Intravenous immunoglobulin therapy for Stevens–Johnson syndrome. South Med J. 2001;94(3): 342–3. [DOI via Crossref] [Pubmed] |
| |
| 2. Tyagi S, Kumar S, Kumar A, Singla M, Singh A. Stevens–Johnson Syndrome—a life threatening skin disorder: a review J Chem Pharm Res. 2010;2(2):618–26. |
| |
| 3. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983;8(6):763–75. [DOI via Crossref] |
| |
| 4. Britz M, Sibulkin D. Recurrent erythema multiforme and Herpes genitalis (type 2). JAMA. 1975;233(7):812–3. [DOI via Crossref] [Pubmed] |
| |
| 5. Gupta SK. Textbook of Pharmacovigilance. 1st edn New Delhi: Jaypee Brothers Medical Publishers. |
| |
| 6. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272–85. [DOI via Crossref] [Pubmed] |
| |
| 7. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981–1985. Arch Dermatol. 1990;126(1):37–42. [DOI via Crossref] [Pubmed] |
| |
| 8. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens–Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92–6. [DOI via Crossref] [Pubmed] |
| |
| 9. Yetiv JZ, Bianchine JR, Owen JA. Etiologic factors of the Stevens– Johnson syndrome. South Med J. 1980;73(5):599–602. [DOI via Crossref] [Pubmed] |
| |
| 10. Bianchine JR, Macaraeg PV, Lasagna L, Azarnoff DL, Brunk SF, Hvidberg EF, et al. Drugs as etiologic factors in the Stevens– Johnson syndrome. Am J Med. 1968;44(3):390–405. [DOI via Crossref] |
| |
| 11. Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. Am J Health Syst Pharm. 2010;67(3):206–13. [DOI via Crossref] [Pubmed] |
| |
| 12. Anne S, Kosanam S, Prasanthi LN. Stevens–Johnson syndrome and toxic epidermal necrolysis: a review Int J Pharmacol Res. 2014; 4(4):158–65. |
| |
| 13. Deore SS, Dandekar RC, Mahajan AM, Shiledar VV. Drug-induced Stevens–Johnson syndrome: A case report. Int J Sci Stud. 2014; 2(4):84–7. |
| |
| 14. Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy. 1999;19(2):223–7. [DOI via Crossref] [Pubmed] |
| |
| 15. Barbosa LA, Teixeira CR. Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. Am J Health Syst Pharm. 2008;65(11):1048–50. [DOI via Crossref] [Pubmed] |
| |
| 16. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology. 2007;68(120):1701–9. [DOI via Crossref] [Pubmed] |
| |
| 17. Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol. 2004;43(1):67–73. [DOI via Crossref] [Pubmed] |
| |
| 18. Cockey GH, Amann ST, Reents SB, Lynch JW. Stevens–Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol. 1996;19(1):32–4. [DOI via Crossref] [Pubmed] |
| |
| 19. Aydin F, Cokluk C, Senturk N, Aydin K, Canturk MT, Turanli AY. Stevens–Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol. 2006; 20(5):588–90. [DOI via Crossref] [Pubmed] |
| |
| 20. Kandil AO, Dvorak T, Mignano J, Wu JK, Zhu JJ. Multifocal Stevens– Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report. Radiat Oncol. 2010; 5:49. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
| |
